2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Reduced Thalamic Nuclei Volume May Contribute to Anxiety in Parkinson’s Disease: a 7-Tesla MRI Study

G. Carey, M. Kuijf, S. Michielse, A. Wolters, K. Dujardin, A. Leentjens (Lille, France)
Refining Aesthetic Eyebrows: Botulinum Toxin Injection for Hemifacial Spasm.

S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)
Refining and Understanding Causal Relationships between Brain Imaging-Derived Phenotypes and Parkinson’s Disease: a Bidirectional Mendelian Randomization Study and Clinical Validation

M. Niu, Y. Zhang (Shanghai, China)
REGENERATE-PD: A Phase 2, Randomized, Double-Blind, Surgery-Controlled Study of GDNF Gene Therapy (AAV2-GDNF; AB-1005) for Moderate Stage Parkinson’s Disease

A. Whone, C. Christine, M. Luz, R. Richardson, C. Urrea, N. Chhabria, C. Letourneau, M. Wisniewski, M. Fiandaca, A. van Laar, A. Kells, K. Bankiewicz (Bristol, United Kingdom)
Regional Brain Volume Differences Across PD Clinical Subtypes

A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, P. Kotzbauer, J. Perlmutter, M. Campbell (SAINT LOUIS, USA)
Regional tau burden patterns and their associations with clinical severity in progressive supranuclear palsy (PSP)-Richardson’s syndrome and PSP- predominant parkinsonism: a prospective cohort study

R. Kim, S. Lee, Y. Kim, B. Jin, S. Kim, H. Kim, S. Shin, H. Kim, J. Lee (Seoul, Republic of Korea)
Relationship Between Non-Motor Symptoms, Kinematic Features, and Quality of Life in Cervical Dystonia

T. Hart, L. Heideman, D. Martino, M. Beudel, A. Sadnicka, F. Morgante (London, United Kingdom)
Relationships of blood Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in 3 Contemporary Clinical Trials

C. Christine, P. Auinger, E. Forti, L. Tat, N. Cannizzaro, D. Oakes, R. Green (San Francisco, USA)
Reliability and Validity of the English Version of the Parkinson Anxiety Scale

J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)
Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations

J. Lavine, A. Scotina, S. Haney, E. Izmailova, L. Omberg (New York, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z